范可尼贫血的研究进展

陈桂林, 刘新月. 范可尼贫血的研究进展[J]. 临床血液学杂志, 2020, 33(1): 75-78. doi: 10.13201/j.issn.1004-2806.2020.01.017
引用本文: 陈桂林, 刘新月. 范可尼贫血的研究进展[J]. 临床血液学杂志, 2020, 33(1): 75-78. doi: 10.13201/j.issn.1004-2806.2020.01.017
CHEN Guilin, LIU Xinyue. Advances in research of Fanconi anemia[J]. J Clin Hematol, 2020, 33(1): 75-78. doi: 10.13201/j.issn.1004-2806.2020.01.017
Citation: CHEN Guilin, LIU Xinyue. Advances in research of Fanconi anemia[J]. J Clin Hematol, 2020, 33(1): 75-78. doi: 10.13201/j.issn.1004-2806.2020.01.017

范可尼贫血的研究进展

详细信息
    通讯作者: 刘新月,E-mail:lxy87306548@sina.com
  • 中图分类号: R556

Advances in research of Fanconi anemia

More Information
  • 范可尼贫血(Fanconi anemia,FA)是一种罕见的常染色体或X染色体隐性遗传性疾病,其发病率为(1~5)/107,为先天性造血衰竭性疾病中最常见的一种,主要与基因组的不稳定性有关。现已发现22种FA亚型,仅FANCB亚型为X染色体隐性遗传[1]。FA传统上被认为是一种儿科疾病,因文献中报道FA的诊断中位年龄在7岁以下,只有9%的患者发生在成年[2]。FA临床表现异质性明显,主要有骨髓造血衰竭、先天性畸形(如畸形手臂、身材矮小、
  • 加载中
  • [1]

    Joenje H,Patel KJ.The emerging genetic and molecular basis of Fanconi anaemia[J].Nat Rev Genet,2001,2:446-457.

    [2]

    Alter BP.Diagnosis,genetics,and management of inherited bone marrow failure syndromes[J].Hematology Am Soc Hematol Educ Program,2007,2007:29-39.

    [3]

    Nepal M,Che R,Zhang J,et al.Fanconi Anemia Signaling and Cancer[J].Trends Cancer,2017,3:840-856.

    [4]

    Howlett NG,Taniguchi T,Olson S,et al.Biallelic inactivation of BRCA2 in Fanconi anemia[J].Science,2002,297:606-609.

    [5]

    Auerbach AD.Fanconi anemia and its diagnosis[J].Mutat Res,2009,668:4-10.

    [6]

    Du W,Amarachintha S,Wilson AF,et al.SCO2 mediates oxidative stress-induced glycolysis to oxidative phosphorylation switch in hematopoietic stem cells[J].Stem Cells,2016,34:960-971.

    [7]

    Li X,Wu L,Zopp M,et al.p53-TIGAR axis-mediated glycolytic suppression attenuates DNA damage and genomic instability in Fanconi anemia hematopoietic stem cells[J].Stem Cells,2019,37:937-947.

    [8]

    Kottemann MC,Smogorzewska A.Fanconi anaemia and the repair of Watson and Crick DNA crosslinks[J].Nature,2013,493:356-363.

    [9]

    Myers KC,Sauter S,Zhang X,et al.Impaired immune function in children and adults with Fanconi anemia[J].Pediatr Blood Cancer,2017,64(11).doi:10.1002/pbc.26599.Epub 2017 May 30.

    [10]

    Rahman N,Seal S,Thompson D,et al.PALB2,which encodes a BRCA2-interacting protein,is a breast cancer susceptibility gene[J].Nat Genet,2007,39:165-167.

    [11]

    Oostra AB,Nieuwint AW,Joenje H,et al.Diagnosis of fanconi anemia:chromosomal breakage analysis[J].Anemia,2012,2012:238731.

    [12]

    王冉,姚东亚,盛光耀.范可尼贫血诊治研究进展[J].世界临床药物,2017,38(6):377-380.

    [13]

    Lim ET,Wurtz P,Havulinna AS,et al.Distribution and medical impact of loss-of-function variants in the Finnish founder population[J].PLoS Genet,2014,10:e1004494.

    [14]

    Garcia MJ,Fernandez V,Osorio A,et al.Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families[J].Breast Cancer Res Treat,2009,113:545-551.

    [15]

    MacMillan ML,DeFor TE,Young JA,et al.Alternative donor hematopoietic cell transplantation for Fanconi anemia[J].Blood,2015,125:3798-804.

    [16]

    杜振兰,司英健,陈伟,等.TCRαβ+CD19+细胞去除的亲缘单倍型移植挽救性治疗范可尼贫血转急性髓系白血病1例伴文献复习[J].中国临床医生杂志,2018,46(11):1291-1295.

    [17]

    Balashov D,Laberko A,Shcherbina A,et al.A Conditioning regimen with plerixafor is safe and improves the outcome of TCRalphabeta(+)and CD19(+)celldepleted stem cell transplantation in patients with Wiskott-Aldrich syndrome[J].Biol Blood Marrow Transplant,2018,24:1432-1440.

    [18]

    Shah RM,Elfeky R,Nademi Z,et al.T-cell receptor alphabeta(+)and CD19(+)cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency[J].J Allergy Clin Immunol,2018,141:1417-1426.e1.

    [19]

    Tolar J,Becker PS,Clapp DW,et al.Gene therapy for Fanconi anemia:one step closer to the clinic[J].Hum Gene Ther,2012,23:141-144.

  • 加载中
计量
  • 文章访问数:  424
  • PDF下载数:  78
  • 施引文献:  0
出版历程
收稿日期:  2019-04-15

目录